A Study To Assess The Feasibility Of Indivi Mobile Application In Monitoring Cognitive Performance In Aging Population
NCT ID: NCT07174869
Last Updated: 2025-09-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
55 participants
OBSERVATIONAL
2025-09-30
2026-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The main questions it aims to answer are:
* Does the DDA system reach a stable difficulty level at the same rate for both PwMCI/AD and HC?
* Is the stable difficulty level reached by the DDA system different for PwMCI/AD compared to HC?
Researchers will also compare cognitive activities results and other aspects of the mobile application's performance to see if the application can validly distinguish between the two groups.
Participants will use the Indivi mobile application, with its embedded DDA system, for a 6-week period.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Computer-based Cognitive Rehabilitation Program for Healthy Older Adults, Older People With Mild Cognitive Impairment and Mild Dementia
NCT03430401
Remember Stuff: A Dyadic-focused Technology to Support Persons With Alzheimer's Disease in the Community
NCT04626804
Individualized Brain Stimulation to Improve Mobility in Alzheimer's Disease
NCT04289402
Efficacy of a Multicomponent Cognitive Intervention in Adults With Subjective Cognitive Decline and Mild Cognitive Impairments
NCT04023032
Tracking Technologies for the Analysis of Mobility in Alzheimer's Disease
NCT00743418
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
PwMCI/AD
Persons with Mild Cognitive Impairment or mild Alzheimer's Disease
No interventions assigned to this group
HC
Healthy Controls
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Participant is diagnosed with MCI, mild AD, or is classified as HC per BU-ADRC, with available required data for inclusion obtained less than 2 years before the inclusion.
* Participant is between 50 and 90 years old, included.
* Participant is able to use a smartphone.
* Participant has sufficient knowledge of the English language.
* Participant is able to and has an intention to follow the study procedures.
* Informed Consent as documented by signature.
Exclusion Criteria
* Participant has psychiatric diagnosis or symptoms, (e.g., hallucinations, major depression, or delusions) that could interfere with study procedures.
* Participant has a history of stroke or seizures within the last 24 months.
* Participant has a Geriatric Depression Scale (GDS) score ≥8.
* Participant has a severe visual or hearing impairment that would interfere with capacity to perform cognitive assessments.
* Known or suspected non-compliance.
50 Years
90 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Indivi AG
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Boston University School of Medicine
Boston, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
H-45373
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.